UBS AM’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-499,048
| Closed | -$12.1M | – | 2740 |
|
|
2023
Q2 | $12.1M | Hold |
499,048
| – | – | 0.01% | 893 |
|
|
2023
Q1 | $12.1M | Buy |
499,048
+379,651
| +318% | +$9.24M | 0.01% | 893 |
|
|
2022
Q4 | $2.56M | Buy |
119,397
+8,590
| +8% | +$184K | ﹤0.01% | 1426 |
|
|
2022
Q3 | $1.99M | Sell |
110,807
-291
| -0.3% | -$5.22K | ﹤0.01% | 1598 |
|
|
2022
Q2 | $1.07M | Buy |
111,098
+16,251
| +17% | +$156K | ﹤0.01% | 1919 |
|
|
2022
Q1 | $1.6M | Buy |
94,847
+17,993
| +23% | +$303K | ﹤0.01% | 1910 |
|
|
2021
Q4 | $1.28M | Buy |
76,854
+10,112
| +15% | +$169K | ﹤0.01% | 2070 |
|
|
2021
Q3 | $1.08M | Sell |
66,742
-14,698
| -18% | -$239K | ﹤0.01% | 2124 |
|
|
2021
Q2 | $514K | Buy |
81,440
+2,589
| +3% | +$16.3K | ﹤0.01% | 2527 |
|
|
2021
Q1 | $487K | Buy |
78,851
+21,451
| +37% | +$133K | ﹤0.01% | 2401 |
|
|
2020
Q4 | $397K | Buy |
+57,400
| New | +$397K | ﹤0.01% | 2361 |
|
|
2016
Q4 | – | Sell |
-17,066
| Closed | -$787K | – | 2709 |
|
|
2016
Q3 | $787K | Buy |
17,066
+2,419
| +17% | +$112K | ﹤0.01% | 1772 |
|
|
2016
Q2 | $748K | Buy |
14,647
+4,108
| +39% | +$210K | ﹤0.01% | 1770 |
|
|
2016
Q1 | $445K | Sell |
10,539
-7,512
| -42% | -$317K | ﹤0.01% | 1986 |
|
|
2015
Q4 | $1.42M | Buy |
18,051
+5,112
| +40% | +$401K | ﹤0.01% | 1607 |
|
|
2015
Q3 | $524K | Buy |
12,939
+2,751
| +27% | +$111K | ﹤0.01% | 1996 |
|
|
2015
Q2 | $530K | Buy |
10,188
+5,188
| +104% | +$270K | ﹤0.01% | 2034 |
|
|
2015
Q1 | $233K | Buy |
+5,000
| New | +$233K | ﹤0.01% | 2407 |
|